Phreesia, Inc. (NYSE: PHR) Stock Competitors & Peer Comparison
See PHR's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PHR and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHR | $10.92 | -7.81% | 734.3M | 42.43 | $0.28 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $60.68 | +2.56% | 11.8B | 48.59 | $1.24 | N/A |
| BTSGU | $200.32 | +2.71% | 11.7B | 179.93 | $1.11 | N/A |
| TEM | $63.49 | +1.96% | 10.9B | -123.88 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $98.82 | +1.87% | 8.2B | 23.02 | $4.28 | N/A |
| TXG | $62.09 | +3.52% | 7.8B | -104.49 | -$0.59 | N/A |
| HNGE | $89.44 | -0.64% | 7.1B | 49.11 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
PHR vs GEHCV Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas GEHCV's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, PHR is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for PHR.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
PHR vs BTSG Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, BTSG has a market cap of 11.8B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while BTSG trades at $60.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas BTSG's P/E ratio is 48.59. In terms of profitability, PHR's ROE is +0.03%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, PHR is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
PHR vs BTSGU Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, BTSGU has a market cap of 11.7B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while BTSGU trades at $200.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas BTSGU's P/E ratio is 179.93. In terms of profitability, PHR's ROE is +0.03%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, PHR is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for PHR.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
PHR vs TEM Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, TEM has a market cap of 10.9B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while TEM trades at $63.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas TEM's P/E ratio is -123.88. In terms of profitability, PHR's ROE is +0.03%, compared to TEM's ROE of -0.55%. Regarding short-term risk, PHR is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
PHR vs SGFY Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SGFY's P/E ratio is 70.91. In terms of profitability, PHR's ROE is +0.03%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, PHR is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
PHR vs HQY Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, HQY has a market cap of 8.2B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while HQY trades at $98.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas HQY's P/E ratio is 23.02. In terms of profitability, PHR's ROE is +0.03%, compared to HQY's ROE of +0.11%. Regarding short-term risk, PHR is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
PHR vs TXG Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, TXG has a market cap of 7.8B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while TXG trades at $62.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas TXG's P/E ratio is -104.49. In terms of profitability, PHR's ROE is +0.03%, compared to TXG's ROE of -0.09%. Regarding short-term risk, PHR is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
PHR vs HNGE Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, HNGE has a market cap of 7.1B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while HNGE trades at $89.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas HNGE's P/E ratio is 49.11. In terms of profitability, PHR's ROE is +0.03%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, PHR is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
PHR vs RCM Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas RCM's P/E ratio is -102.21. In terms of profitability, PHR's ROE is +0.03%, compared to RCM's ROE of +0.00%. Regarding short-term risk, PHR is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check RCM's competition here
Waystar Holding Corp. (NASDAQ: WAY)
PHR vs WAY Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, WAY has a market cap of 4.9B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while WAY trades at $25.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas WAY's P/E ratio is 17.03. In terms of profitability, PHR's ROE is +0.03%, compared to WAY's ROE of +0.04%. Regarding short-term risk, PHR is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check WAY's competition here
Doximity, Inc. (NYSE: DOCS)
PHR vs DOCS Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, DOCS has a market cap of 4.9B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while DOCS trades at $26.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas DOCS's P/E ratio is 17.20. In terms of profitability, PHR's ROE is +0.03%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for PHR.Check DOCS's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
PHR vs HTFL Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, HTFL has a market cap of 4.3B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while HTFL trades at $49.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas HTFL's P/E ratio is -24.88. In terms of profitability, PHR's ROE is +0.03%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, PHR is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for PHR.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
PHR vs ONEM Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas ONEM's P/E ratio is -7.77. In terms of profitability, PHR's ROE is +0.03%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, PHR is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
PHR vs PRVA Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, PRVA has a market cap of 2.6B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while PRVA trades at $20.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas PRVA's P/E ratio is 98.67. In terms of profitability, PHR's ROE is +0.03%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, PHR is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for PHR.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
PHR vs NXGN Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas NXGN's P/E ratio is -266.00. In terms of profitability, PHR's ROE is +0.03%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, PHR is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for PHR.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
PHR vs OMCL Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, OMCL has a market cap of 1.6B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while OMCL trades at $35.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas OMCL's P/E ratio is 18.18. In terms of profitability, PHR's ROE is +0.03%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, PHR is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for PHR.Check OMCL's competition here
Omada Health (NASDAQ: OMDA)
PHR vs OMDA Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while OMDA trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas OMDA's P/E ratio is 333.00. In terms of profitability, PHR's ROE is +0.03%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, PHR is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for PHR.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
PHR vs AGTI Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas AGTI's P/E ratio is -71.79. In terms of profitability, PHR's ROE is +0.03%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, PHR is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
PHR vs CERT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CERT trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CERT's P/E ratio is 20.70. In terms of profitability, PHR's ROE is +0.03%, compared to CERT's ROE of -0.07%. Regarding short-term risk, PHR is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
PHR vs GDRX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while GDRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas GDRX's P/E ratio is 10.78. In terms of profitability, PHR's ROE is +0.03%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, PHR is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
PHR vs TDOC Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while TDOC trades at $6.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas TDOC's P/E ratio is -6.52. In terms of profitability, PHR's ROE is +0.03%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, PHR is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TDOC's competition here
HealthStream, Inc. (NASDAQ: HSTM)
PHR vs HSTM Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, HSTM has a market cap of 869.7M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while HSTM trades at $29.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas HSTM's P/E ratio is 41.35. In terms of profitability, PHR's ROE is +0.03%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, PHR is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
PHR vs CCLDO Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CCLDO's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CCLDO's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
PHR vs SOPH Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SOPH has a market cap of 694.7M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SOPH trades at $8.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SOPH's P/E ratio is -7.46. In terms of profitability, PHR's ROE is +0.03%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, PHR is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SOPH's competition here
Claritev Corporation (NYSE: CTEV)
PHR vs CTEV Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CTEV has a market cap of 685.8M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CTEV trades at $39.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CTEV's P/E ratio is -2.37. In terms of profitability, PHR's ROE is +0.03%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, PHR is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for PHR.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
PHR vs MPLN-WT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, PHR is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
PHR vs ACCD Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas ACCD's P/E ratio is -3.08. In terms of profitability, PHR's ROE is +0.03%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, PHR is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
PHR vs SHCR Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SHCR's P/E ratio is -3.76. In terms of profitability, PHR's ROE is +0.03%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, PHR is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
PHR vs EVH Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, EVH has a market cap of 475.2M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while EVH trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas EVH's P/E ratio is 32.50. In terms of profitability, PHR's ROE is +0.03%, compared to EVH's ROE of -0.99%. Regarding short-term risk, PHR is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for PHR.Check EVH's competition here
NRC Health (NASDAQ: NRC)
PHR vs NRC Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, NRC has a market cap of 451M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while NRC trades at $21.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas NRC's P/E ratio is 24.40. In terms of profitability, PHR's ROE is +0.03%, compared to NRC's ROE of +0.48%. Regarding short-term risk, PHR is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for PHR.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
PHR vs SLGC Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SLGC's P/E ratio is -3.04. In terms of profitability, PHR's ROE is +0.03%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, PHR is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
PHR vs SLGCW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, PHR's ROE is +0.03%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, PHR is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
PHR vs TBRG Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas TBRG's P/E ratio is 9.37. In terms of profitability, PHR's ROE is +0.03%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, PHR is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
PHR vs MPLN Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas MPLN's P/E ratio is -0.23. In terms of profitability, PHR's ROE is +0.03%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, PHR is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
PHR vs SY Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SY has a market cap of 370M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SY trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SY's P/E ratio is -8.55. In terms of profitability, PHR's ROE is +0.03%, compared to SY's ROE of -0.16%. Regarding short-term risk, PHR is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
PHR vs TRHC Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas TRHC's P/E ratio is -4.27. In terms of profitability, PHR's ROE is +0.03%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, PHR is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for PHR.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
PHR vs SMFR Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SMFR's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, PHR is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
PHR vs SPOK Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SPOK has a market cap of 220.6M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SPOK trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SPOK's P/E ratio is 17.60. In terms of profitability, PHR's ROE is +0.03%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, PHR is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
PHR vs AMWL Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, AMWL has a market cap of 218.2M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while AMWL trades at $13.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas AMWL's P/E ratio is -2.90. In terms of profitability, PHR's ROE is +0.03%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, PHR is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AMWL's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
PHR vs LFMDP Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, LFMDP has a market cap of 160.2M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while LFMDP trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas LFMDP's P/E ratio is -724.19. In terms of profitability, PHR's ROE is +0.03%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, PHR is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LFMDP's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
PHR vs OPRX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, OPRX has a market cap of 150.9M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while OPRX trades at $8.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas OPRX's P/E ratio is 7.38. In terms of profitability, PHR's ROE is +0.03%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, PHR is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check OPRX's competition here
LifeMD, Inc. (NASDAQ: LFMD)
PHR vs LFMD Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, LFMD has a market cap of 148.5M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while LFMD trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas LFMD's P/E ratio is -6.14. In terms of profitability, PHR's ROE is +0.03%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, PHR is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LFMD's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
PHR vs CPSI Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CPSI's P/E ratio is -183.80. In terms of profitability, PHR's ROE is +0.03%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, PHR is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for PHR.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
PHR vs HCAT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, HCAT has a market cap of 124.9M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while HCAT trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas HCAT's P/E ratio is 8.45. In terms of profitability, PHR's ROE is +0.03%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, PHR is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for PHR.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
PHR vs AUGX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas AUGX's P/E ratio is -4.99. In terms of profitability, PHR's ROE is +0.03%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, PHR is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AUGX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
PHR vs DH Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, DH has a market cap of 109.7M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while DH trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas DH's P/E ratio is 4.00. In terms of profitability, PHR's ROE is +0.03%, compared to DH's ROE of -0.79%. Regarding short-term risk, PHR is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for PHR.Check DH's competition here
CareCloud, Inc. (NASDAQ: CCLD)
PHR vs CCLD Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CCLD has a market cap of 95.2M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CCLD trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CCLD's P/E ratio is 8.62. In terms of profitability, PHR's ROE is +0.03%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
PHR vs WORX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas WORX's P/E ratio is -6.40. In terms of profitability, PHR's ROE is +0.03%, compared to WORX's ROE of -0.35%. Regarding short-term risk, PHR is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for PHR.Check WORX's competition here
Forian Inc. (NASDAQ: FORA)
PHR vs FORA Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas FORA's P/E ratio is -24.11. In terms of profitability, PHR's ROE is +0.03%, compared to FORA's ROE of -0.17%. Regarding short-term risk, PHR is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for PHR.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
PHR vs CCLDP Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CCLDP's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
PHR vs SNCE Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SNCE's P/E ratio is -0.27. In terms of profitability, PHR's ROE is +0.03%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, PHR is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
PHR vs AKLI Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas AKLI's P/E ratio is -0.71. In terms of profitability, PHR's ROE is +0.03%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, PHR is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
PHR vs SHLT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SHLT's P/E ratio is -3.87. In terms of profitability, PHR's ROE is +0.03%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, PHR is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMD)
PHR vs ONMD Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, ONMD has a market cap of 32.9M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while ONMD trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas ONMD's P/E ratio is -3.61. In terms of profitability, PHR's ROE is +0.03%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, PHR is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ONMD's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
PHR vs SHCRW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, PHR is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
PHR vs ONMDW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, ONMDW has a market cap of 30.2M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas ONMDW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, PHR is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
PHR vs STRM Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas STRM's P/E ratio is -2.40. In terms of profitability, PHR's ROE is +0.03%, compared to STRM's ROE of -0.65%. Regarding short-term risk, PHR is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for PHR.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
PHR vs RNLX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas RNLX's P/E ratio is -0.33. In terms of profitability, PHR's ROE is +0.03%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, PHR is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for PHR.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
PHR vs LIFW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas LIFW's P/E ratio is -0.02. In terms of profitability, PHR's ROE is +0.03%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, PHR is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
PHR vs BBLN Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas BBLN's P/E ratio is -0.04. In terms of profitability, PHR's ROE is +0.03%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, PHR is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for PHR.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
PHR vs ETAO Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas ETAO's P/E ratio is -0.01. In terms of profitability, PHR's ROE is +0.03%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, PHR is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
PHR vs BFRG Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, BFRG has a market cap of 9.1M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while BFRG trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas BFRG's P/E ratio is -1.07. In terms of profitability, PHR's ROE is +0.03%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, PHR is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for PHR.Check BFRG's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
PHR vs MGRX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, MGRX has a market cap of 6.5M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while MGRX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas MGRX's P/E ratio is -0.28. In terms of profitability, PHR's ROE is +0.03%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, PHR is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
PHR vs UPH-WT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, PHR is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for PHR.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
PHR vs UPH Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas UPH's P/E ratio is -0.07. In terms of profitability, PHR's ROE is +0.03%, compared to UPH's ROE of -1.05%. Regarding short-term risk, PHR is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for PHR.Check UPH's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
PHR vs PEAR Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas PEAR's P/E ratio is -0.08. In terms of profitability, PHR's ROE is +0.03%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, PHR is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for PHR.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
PHR vs PEARW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas PEARW's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, PHR is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
PHR vs OTRK Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas OTRK's P/E ratio is -0.02. In terms of profitability, PHR's ROE is +0.03%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, PHR is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for PHR.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
PHR vs CMAX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CMAX's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, PHR is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
PHR vs BFRGW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while BFRGW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, PHR's ROE is +0.03%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, PHR is less volatile compared to BFRGW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check BFRGW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
PHR vs LIFWZ Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, PHR is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LIFWZ's competition here
Aclarion, Inc. (NASDAQ: ACON)
PHR vs ACON Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while ACON trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas ACON's P/E ratio is -0.26. In terms of profitability, PHR's ROE is +0.03%, compared to ACON's ROE of -0.59%. Regarding short-term risk, PHR is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ACON's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
PHR vs HCTI Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, HCTI has a market cap of 947.8K. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while HCTI trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas HCTI's P/E ratio is -0.10. In terms of profitability, PHR's ROE is +0.03%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, PHR is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for PHR.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
PHR vs VSEEW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, PHR's ROE is +0.03%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, PHR is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
PHR vs MSPRZ Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, PHR is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MSPRZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
PHR vs VSEE Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, VSEE has a market cap of 274.9K. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while VSEE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas VSEE's P/E ratio is -0.04. In terms of profitability, PHR's ROE is +0.03%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, PHR is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for PHR.Check VSEE's competition here
Akerna Corp. (NASDAQ: KERNW)
PHR vs KERNW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas KERNW's P/E ratio is -0.00. In terms of profitability, PHR's ROE is +0.03%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, PHR is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
PHR vs KERN Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas KERN's P/E ratio is -0.01. In terms of profitability, PHR's ROE is +0.03%, compared to KERN's ROE of -0.20%. Regarding short-term risk, PHR is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for PHR.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
PHR vs LIFWW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas LIFWW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, PHR is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
PHR vs CMAXW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CMAXW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, PHR is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
PHR vs ZCMD Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, ZCMD has a market cap of 31.2K. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while ZCMD trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, PHR's ROE is +0.03%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, PHR is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for PHR.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
PHR vs ACONW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, ACONW has a market cap of 18.7K. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas ACONW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, PHR is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check ACONW's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
PHR vs IMS Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, IMS has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas IMS's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to IMS's ROE of +0.27%. Regarding short-term risk, PHR is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for PHR.Check IMS's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
PHR vs SMFRW Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas SMFRW's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, PHR is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for PHR.Check SMFRW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
PHR vs MSPRV Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas MSPRV's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MSPRV's ROE of N/A. Regarding short-term risk, PHR is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MSPRV's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
PHR vs CHNGU Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CHNGU's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, PHR is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CHNGU's competition here
CareCloud, Inc. (NASDAQ: MTBC)
PHR vs MTBC Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas MTBC's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, PHR is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for PHR.Check MTBC's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
PHR vs AFFX Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas AFFX's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, PHR is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for PHR.Check AFFX's competition here
Castlight Health, Inc. (NYSE: CSLT)
PHR vs CSLT Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CSLT's P/E ratio is -37.27. In terms of profitability, PHR's ROE is +0.03%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, PHR is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CSLT's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
PHR vs CNVY Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CNVY's P/E ratio is -71.50. In terms of profitability, PHR's ROE is +0.03%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, PHR is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
PHR vs MTBCP Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas MTBCP's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for PHR.Check MTBCP's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
PHR vs NAVA Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas NAVA's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, PHR is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for PHR.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
PHR vs CERN Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CERN has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CERN's P/E ratio is 55.84. In terms of profitability, PHR's ROE is +0.03%, compared to CERN's ROE of +0.14%. Regarding short-term risk, PHR is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CERN's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
PHR vs CHNG Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas CHNG's P/E ratio is -152.72. In terms of profitability, PHR's ROE is +0.03%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, PHR is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for PHR.Check CHNG's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
PHR vs MTBCO Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas MTBCO's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, PHR is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for PHR.Check MTBCO's competition here
NantHealth, Inc. (NASDAQ: NH)
PHR vs NH Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, NH has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas NH's P/E ratio is -0.12. In terms of profitability, PHR's ROE is +0.03%, compared to NH's ROE of +0.35%. Regarding short-term risk, PHR is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for PHR.Check NH's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
PHR vs KURIU Comparison September 2026
Phreesia, Inc. (NYSE: PHR) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHR stands at 734.3M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, PHR is priced at $10.92 on the NYSE, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHR currently has a P/E ratio of 42.43, whereas KURIU's P/E ratio is N/A. In terms of profitability, PHR's ROE is +0.03%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, PHR is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for PHR.Check KURIU's competition here